We also report that DYRK1A is required to suppress the proapoptotic molecule BIM and that DYRK1A inhibition consequently renders KMT2A-R ALL cells sensitive to BCL2 inhibition. The gene discussed is DYRK1A; the disease is acute lymphoblastic leukemia.